Donati, Gabriele
 Distribuzione geografica
Continente #
AS - Asia 10.497
NA - Nord America 8.943
EU - Europa 5.292
SA - Sud America 2.317
AF - Africa 232
OC - Oceania 26
Continente sconosciuto - Info sul continente non disponibili 9
Totale 27.316
Nazione #
US - Stati Uniti d'America 8.633
SG - Singapore 2.896
CN - Cina 2.670
IT - Italia 1.950
HK - Hong Kong 1.855
BR - Brasile 1.808
VN - Vietnam 1.369
GB - Regno Unito 681
FI - Finlandia 552
SE - Svezia 471
KR - Corea 456
RU - Federazione Russa 376
BD - Bangladesh 307
DE - Germania 261
AR - Argentina 201
ID - Indonesia 198
BG - Bulgaria 177
IN - India 177
NL - Olanda 155
FR - Francia 139
MX - Messico 127
CA - Canada 108
ES - Italia 89
EC - Ecuador 78
IE - Irlanda 74
IQ - Iraq 71
TR - Turchia 61
AT - Austria 60
PK - Pakistan 60
CO - Colombia 58
ZA - Sudafrica 58
UA - Ucraina 57
JP - Giappone 54
PY - Paraguay 52
AE - Emirati Arabi Uniti 43
PL - Polonia 40
CZ - Repubblica Ceca 38
VE - Venezuela 38
MA - Marocco 35
UZ - Uzbekistan 33
CL - Cile 32
EG - Egitto 30
SA - Arabia Saudita 30
MY - Malesia 28
KE - Kenya 27
LT - Lituania 27
TN - Tunisia 26
AU - Australia 25
TW - Taiwan 25
PE - Perù 23
GR - Grecia 20
CH - Svizzera 19
IR - Iran 19
PH - Filippine 19
TH - Thailandia 18
UY - Uruguay 18
RO - Romania 17
AZ - Azerbaigian 16
DZ - Algeria 16
CR - Costa Rica 13
BE - Belgio 12
NP - Nepal 12
JM - Giamaica 11
AL - Albania 10
JO - Giordania 10
GT - Guatemala 9
KZ - Kazakistan 9
LB - Libano 9
NO - Norvegia 9
PT - Portogallo 9
BH - Bahrain 8
BO - Bolivia 8
ET - Etiopia 8
IL - Israele 8
DO - Repubblica Dominicana 7
HN - Honduras 7
KG - Kirghizistan 7
PR - Porto Rico 7
TT - Trinidad e Tobago 7
DK - Danimarca 6
HU - Ungheria 6
BY - Bielorussia 5
EU - Europa 5
NI - Nicaragua 5
SI - Slovenia 5
SK - Slovacchia (Repubblica Slovacca) 5
SN - Senegal 5
BA - Bosnia-Erzegovina 4
BW - Botswana 4
KH - Cambogia 4
QA - Qatar 4
RS - Serbia 4
BF - Burkina Faso 3
CI - Costa d'Avorio 3
EE - Estonia 3
HR - Croazia 3
LK - Sri Lanka 3
NG - Nigeria 3
OM - Oman 3
PA - Panama 3
Totale 27.267
Città #
Santa Clara 2.092
Hong Kong 1.845
Singapore 1.631
Ashburn 1.133
Hefei 917
San Jose 720
London 526
Helsinki 516
Ho Chi Minh City 453
Seoul 445
Beijing 389
Council Bluffs 356
Nyköping 339
Hanoi 312
The Dalles 305
Los Angeles 238
Chandler 218
Milan 218
Princeton 210
New York 207
Fairfield 194
São Paulo 177
Sofia 172
Buffalo 136
Wilmington 136
Moscow 124
Chicago 116
San Diego 113
Rome 107
Jakarta 102
Bologna 89
Dallas 88
Shanghai 83
Naples 75
Lauterbourg 70
Dublin 65
Nuremberg 65
Haiphong 64
Houston 64
Modena 64
Redondo Beach 63
Woodbridge 56
Kent 53
Da Nang 52
Rio de Janeiro 52
Seattle 51
Guangzhou 50
Amsterdam 47
Salt Lake City 47
Munich 45
Orem 43
Mexico City 42
Hải Dương 38
Tokyo 38
Boardman 34
Norwalk 34
Reggio Emilia 34
Frankfurt am Main 33
Porto Alegre 33
Cambridge 31
Curitiba 31
Chennai 30
Tashkent 30
Toronto 30
Guayaquil 28
Parma 28
Turin 28
Baghdad 27
Warsaw 27
Biên Hòa 26
Brasília 26
Florence 26
Vienna 25
Brooklyn 24
Palermo 24
Tampa 24
Belo Horizonte 23
Denver 23
Nairobi 23
Phoenix 23
Quito 23
Thái Bình 23
Lappeenranta 22
Asunción 21
Badalona 21
Elk Grove Village 21
Johannesburg 21
Madrid 20
Montreal 20
Salvador 20
Bari 19
Buenos Aires 19
Thái Nguyên 19
Can Tho 18
Rimini 18
Atlanta 17
Changsha 17
Istanbul 17
Manaus 17
Goiânia 16
Totale 16.965
Nome #
Reazioni di intolleranza a membrane di dialisi sintetiche e loro risoluzione con membrane alternative 563
Automated Prediction of Kidney Failure in IgA Nephropathy with Deep Learning from Biopsy Images 323
Assessment and Management of Transplant Renal Artery Stenosis. A Literature Review 274
COVID-19 Rapid Antigen Test Screening in Patients on Hemodialysis 238
Coupled plasma filtration and adsorption (CPFA) for extracorporeal detoxification during acute or acute on chronic liver failure 228
Combining telemedicine and in-person visits to deliver care to patients with severe chronic kidney disease (CKD): Lessons learned from COVID-19 214
Awaiting a cure for COVID-19: therapeutic approach in patients with different severity levels of COVID-19 211
Early use of PEPA dialyzer for light chains removal and for the recovery from myeloma cast nephropathy: a case report 201
Risk of bleeding after percutaneous native kidney biopsy in patients receiving low-dose aspirin: a single-center retrospective study 199
Acute systemic, splanchnic and renal haemodynamic changes induced by molecular adsorbent recirculating system (MARS) treatment in patients with end-stage cirrhosis 197
Mycophenolate mofetil plus steroids compared to steroids alone in IgA nephropathy: a retrospective study 195
Weekly Rapid Antigen Test Screening for COVID-19 in Patients on Hemodialysis 195
A Comparison of Two Surgical Techniques for the Second Stage of Brachiobasilic Arteriovenous Fistula Creation 193
Immunosuppressive therapy reduction and early post-infection graft function in kidney transplant recipients with COVID-19 188
Risk of infections related to endovascular catheters and cardiac implantable devices in hemodialysis patients 184
PATIENT AND TECHNIQUE SURVIVAL ON PERITONEAL DIALYSIS: A RETROSPECTIVE STUDY 177
Prolonged RT-PCR test positivity in hemodialysis patients with COVID-19 175
Acute Myeloma Kidney: free light chains removal associated with chemotherapy for patients and kidney survival 175
Reversed high-flux SUPRA HFR: a proof of concept pilot study to access the middle molecular weight uremic toxins 174
Sodium Prescription in the Prevention of Intradialytic Hypotension: New Insights into an Old Concept? 174
Ongoing Peritoneal Dialysis Training at Home Allows for the Improvement of Patients’ Empowerment: A Single Center Experience 173
Coupled Plasma Filtration Adsorption: A Multipurpose Extracorporeal Detoxification Therapy 173
Anti-SARS-COV-2 antibodies in patients on maintenance hemodialysis 172
Primary membranous nephropathy in the Italian region of Emilia Romagna: results of a multicenter study with extended follow-up 172
Which criteria should we use to end isolation in hemodialysis patients with COVID-19? 169
Using MRI Texture Analysis Machine Learning Models to Assess Graft Interstitial Fibrosis and Tubular Atrophy in Patients with Transplanted Kidneys 169
Rethinking Chronic Kidney Disease in the Aging Population 168
"Green" Hemodialysis: The Centralized Acidic Concentrate from the Dialysis Center of Policlinico of Modena 167
SURVIVAL OF HEMODIALYSIS PATIENTS: A LARGE RETROSPECTIVE STUDY 164
A case of Paget's disease in hemodialysis 164
Ethical challenges in managing unvaccinated patients receiving chronic in-centre haemodialysis 162
Central delivery of acid concentrate for haemodialysis: a single center experience 161
REMOVAL OF LARGE-MIDDLE MOLECULES, INHIBITION OF NEUTROPHIL ACTIVATION AND MODULATION OF INFLAMMATION-RELATED ENDOTHELIAL DYSFUNCTION DURING EXPANDED HEMODIALYSIS (HDX) 160
STUDY ON THE MECHANICAL PROPERTIES OF THE TISSUES OF THE GREAT ARTERIES 158
Eradication of Staphylococcus aureus carriage in patients undergoing peritoneal dialysis 157
MARS and Prometheus: our clinical experience in acute chronic liver failure 157
Acute myeloma kidney and SARS-COV2 infection with dialysis need: never say never - a case report 156
Exploring the Role of Cell-Free Nucleic Acids and Peritoneal Dialysis: A Narrative Review 154
Towards the monitoring of dialysis treatment through absorption and endogenous fluorescence techniques 153
Risk of complications after percutaneous native kidney biopsy in patients receiving anti-platelet agents 151
Evaluating Short-Term Outcomes of Tunneled and Non-Tunneled Central Venous Catheters in Hemodialysis 151
COVID-19 in patients on Peritoneal Dialysis: a case series 151
Accessi vascolari estremi in emodialisi: posizionamento chirurgico di catetere di Tesio in vena iliaca comune destra 150
Efficacy of Supra-HFR in Removing FGF23 and Cytokines: A Single Session Analysis 149
MAGNETIC RESONANCE RADIOMIC ANALYSIS FOR THE PREDICTION OF GRAFT FAILURE IN PATIENTS WITH KIDNEY TRANSPLANTATION 145
QTC INTERVAL, POTASSIUM AND ELECTROLYTES KINETICS DURING AND AFTER DIALYSIS WITH SUPRA HFR (PANDORA STUDY) 143
Vacuum assisted thromboaspiration with Indigo system after acute arteriovenous fistula thrombosis: monocentric experience of an innovative interventional approach 142
Role of the hemodialysis vascular access type in inflammation status and monocyte activation 141
Reactogenicity of MRNA-1273 vaccine in patients on hemodialysis 140
Il centro dialisi ecosostenibile 140
Rimozione delle catene leggere libere mediante diverse tipologie di filtri dializzatori in pazienti con danno renale acuto da mieloma multiplo 139
Anti-inflammatory approach in chronic dialysis patients with SARS-COV-2: ATA or PMMA dialyzers? 138
Scheduling of Remote Monitoring for Peritoneal Dialysis Patients 138
Effects of listening to live singing in patients undergoing hemodialysis: a randomized controlled crossover study 138
New mineralocorticoid receptor antagonists: update on their use in chronic kidney disease and heart failure 137
Analisi di sequenza e di espressione del gene della beta-2 microglobulina in pazienti dializzati 136
Reactogenicity of COVID-19 vaccine in hemodialysis patients: a single-center retrospective study 135
Comorbidity and in-hospital mortality in peritoneal dialysis patients: data of the Emilia Romagna region of Italy 135
Rationale and design of the CORDIAL first-in-human clinical trial: a system for sorbent-assisted continuous flow peritoneal dialysis 130
Metabolic syndrome after kidney transplantation 130
Sarcoidosis in a living donor candidate: case report and review of the literature 129
Screening for nasal carriage of Staphylococcus (S.) aureus reduces the risk of S. aureus peritonitis in patients on peritoneal dialysis (PD) 127
Sparsentan in patients with IgA nephropathy: a prespecified interim analysis from a randomised, double-blind, active-controlled clinical trial 127
Attivazione infiammatoria durante la dialisi: emodialisi vs.Emodiafiltrazione (HDF) on-line 127
Prevalence, clinical course and outcomes of COVID-19 in peritoneal dialysis (PD) patients: a single-center experience 127
Early Light Chains Removal and Albumin Levels with a Double Filter-Based Extracorporeal Treatment for Acute Myeloma Kidney 125
5-Methyltetrahydrofolate Administration Is Associated with Prolonged Survival and Reduced Inflammation in ESRD Patients 125
An in vivo autotransplant model of renal preservation: cold storage versus machine perfusion in the prevention of ischemia/reperfusion injury 123
ACUTE MYELOMA KIDNEY: EFFICACY OF DOUBLE FILTER BASED EXTRACORPOREAL TREATMENTS COMBINED TO CHEMOTHERAPY FOR PATIENT AND KIDNEY SURVIVAL 123
Optimal urokinase lock therapy for hemodialysis (HD) tunnelled cuffed catheter (TCC) thrombosis 122
Safety of Intradialytic Bamlanivimab/ Etesevimab Administration in Two COVID-19 Dialysis Outpatients 122
Very Early BK polyomavirus viremia is associated with graft dysfunction in kidney transplant recipients 121
Anti-Inflammatory Approach in Chronic Dialysis Patients with SARS-CoV-2: ATA or PMMA Dialyzers? 121
Pulse wave propagation in blood vessels:theoretical investigation and clinical applications 121
PTFE Grafts Versus Tunneled Cuffed Catheters for Hemodialysis: Which Is the Second Choice When Arteriovenous Fistula Is Not Feasible? 120
The Use of Supra-Hemodiafiltration in Traumatic Rhabdomyolysis and Acute Kidney Injury: A Case Report 119
Hepatorenal syndrome: Update on diagnosis and treatment 119
Improving the sustainability and quality of kidney health care through life cycle assessments, quality improvement, education and technical innovations: the KitNewCare approach 118
EPIDEMIOLOGICAL AND CLINICAL CHARACTERISTICS OF MIGRANTS ON CHRONIC HEMODIALYSIS TREATMENT 117
Middle-Molecular Weight Toxin Removal: Asymmetric Cellulose Triacetate vs. Helicoidal Polysulfone during Online Hemodiafiltration (CHORALS Study) 117
Mathematical Model of Potassium Profiling in chronic Dialysis 117
A MID-TERM REPORT OF HD TREATMENTS WITH THE NEW DIALYZERS WITH MEDIUM CUT-OFF MEMBRANE (MCO THERANOVA) 117
Eparina non frazionata vs eparina a basso peso molecolare: effetti sui livelli plasmatici di osteoprotegerina, RANKL e citochine infiammatorie in dialisi 117
Accesso vascolare e infiammazione: fistola arterovenosa (FAV) vs protesi in PTFE vs cateteri venosi centrali a permanenza (TCC) 116
Migrants on hemodialysis (HD): clinical characteristics, outcome and quality of life 115
Outcomes of radiocephalic arteriovenous fistula in octogenarians 114
5-MTHF vs Folic Acid therapy on hyperomocysteinemia and Endothelial function in dialysis patients 114
ANCA-Associated vasculitis in the very elderly: A 90-year-old iron lady 113
Extracorporeal Detoxification for Hepatic Failure Using Molecular Adsorbent Recirculating System: Depurative Efficiency and Clinical Results in a Long-Term Follow-Up 112
Doppia Filtrazione a cascata (DFPP) nel trattamento del rigetto umorale di trapianto di rene: case report 111
Uremic toxins removal and iron status: a medium-term comparison between 4 dialysis techniques (EMPIRE study) 109
Hemoadsorption and plasma adsorption: two current options for the 3rd dimension of dialysis purification 109
Dialyzability of Oxycodone and Its Metabolites in Chronic Noncancer Pain Patients with End-Stage Renal Disease 109
A new mathematical model for profiled-HFR 109
Sickle Cell Trait and SARS-CoV-2-Induced Rhabdomyolysis: A Case Report 109
Impact of Single Hemodialysis Treatment on immune Cell Subpopulations 107
Immunological effects of a single hemodialysis treatment 107
Comparison of Two Parathyroid Hormone Assays in Hemodialysis Patients 107
Effect of Vitamin D Receptor Activator Therapy on Vitamin D Receptor and Osteocalcin Expression in Circulating Endothelial Progenitor Cells of Hemodialysis Patients 107
Depurazione extracorporea mediante Coupled plasma filtration and adsorption (CPFA) in corso di insufficienza epatica acuta e acuta su cronica (studio HERCOLE) 106
Totale 15.221
Categoria #
all - tutte 144.657
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 144.657


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.667 0 0 0 0 0 415 72 100 333 75 418 254
2022/20231.514 210 138 108 90 121 171 125 124 175 50 94 108
2023/20242.483 76 74 139 298 423 142 110 467 215 157 106 276
2024/20257.939 174 96 160 590 1.579 1.208 309 358 1.001 811 654 999
2025/202614.018 816 707 1.611 2.321 1.223 525 1.824 991 1.253 1.296 1.317 134
Totale 27.621